Ischemic preconditioning (IPC) is a robust neuroprotective phenomenon whereby brief ischemic exposure confers tolerance to a subsequent ischemic challenge. IPC has not been studied selectively in CNS white matter (WM), although stroke frequently involves WM. We determined whether IPC is present in WM and, if so, its mechanism. We delivered a briefin vivopreconditioning ischemic insult (unilateral common carotid artery ligation) to 12- to 14-week-old mice and determined WM ischemic vulnerability [oxygen–glucose deprivation (OGD)] 72 h later, using acutely isolated optic nerves (CNS WM tracts) from the preconditioned (ipsilateral) and control (contralateral) hemispheres. Functional and structural recovery was assessed by quantitative measurement of compound action potentials (CAPs) and immunofluorescent microscopy. Preconditioned mouse optic nerves (MONs) showed better functional recovery after OGD than the non-preconditioned MONs (31 ± 3 vs 17 ± 3% normalized CAP area,p< 0.01). Preconditioned MONs also showed improved axon integrity and reduced oligodendrocyte injury compared with non-preconditioned MONs. Toll-like receptor-4 (TLR4) and type 1 interferon receptor (IFNAR1), key receptors in innate immune response, are implicated in gray matter preconditioning. Strikingly, IPC-mediated WM protection was abolished in bothTLR4−/−andIFNAR1−/−mice. In addition, IPC-mediated protection in WM was also abolished inIFNAR1fl/flLysMcre, but not inIFNAR1fl/flcontrol, mice. These findings demonstrated for the first time that IPC was robust in WM, the phenomenon being intrinsic to WM itself. Furthermore, WM IPC was dependent on innate immune cell signaling pathways. Finally, these data demonstrated that microglial-specific expression of IFNAR1 plays an indispensable role in WM IPC.SIGNIFICANCE STATEMENTIschemic preconditioning (IPC) has been studied predominantly in gray matter, but stroke in humans frequently involves white matter (WM) as well. Here we describe a novel, combinedin vivo/ex vivomouse model to determine whether IPC occurs in WM. It does. Using genetically altered mice, we identified two innate immune cell receptors, Toll-like receptor 4 and type 1 interferon receptor (IFNAR1), that are required for IPC-mediated protection in WM. Furthermore, using microglia-targeted IFNAR1 knockdown, we demonstrate that interferon signaling specifically in microglia is essential for this protection. The discovery of IPC as an intrinsic capability of WM is novel and important. This is also the firstin vivodemonstration that cell-type-specific expression of an individual gene plays an indispensable role in IPC-mediated protection.
Background: Pharmacologic venous thromboembolism (VTE) prophylaxis following spine surgery is not standardized. This study aims to compare the rates of VTE between patients receiving chemoprophylaxis vs. no chemoprophylaxis following elective spine surgery. Methods: A comprehensive investigation of searchable electronic databases was performed to capture randomized controlled trials (RCTs) comparing VTE chemoprophylaxis with no chemoprophylaxis after elective spine surgery. Two authors examined the eligibility, risk of bias and quality of studies using the Grades of Recommendation Assessment, Development and Evaluation (GRADE) criteria. Meta-analyses were conducted for risk of developing VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE), significant bleeding, and epidural hematoma. Results: After appraising 2,666 articles, eight RCTs were ultimately included in the analysis. These trials involved 1,509 patients, with 1,151 receiving VTE chemoprophylaxis and 358 not receiving it. No significant differences were found between the groups in the incidence of VTE [risk ratio (RR): 1.01; 95% confidence interval (CI): 0.97, 1.05; P=0.68] or DVT (RR: 1.03; 95% CI: 0.99, 1.06; P=0.11). Additionally, there were no significant differences in the risk of severe bleeding (RR: 1.01; 95% CI: 0.97, 1.05; P=0.59), significant bleeding (RR: 1.01; 95% CI: 0.97, 1.04; P=0.75), PE (RR: 1.00; 95% CI: 0.96, 1.03; P=0.81), or epidural hematoma (RR: 1.00; 95% CI: 0.97, 1.03; P>0.99) between the groups. Conclusions: This systematic review and meta-analysis did not find a statistically significant difference in the efficacy of routine use of VTE chemoprophylaxis following elective spine surgery with moderate-quality evidence. Future well-designed randomized trials with adequate power are still needed to assess the safety and efficacy of VTE chemoprophylaxis, especially considering the variability of surgical techniques in elective spine surgery.
The surgical management of adult spinal deformities (ASDs) involves a wide variety of complex and technically challenging operative techniques. Despite numerous publications examining the relationship between surgeon experience and outcomes in ASD, no systematic review or meta-analysis exists. This first-time systematic review and meta-analysis examines the impact of surgeon experience on the surgical parameters and complication rates for the surgical management of ASD. Four databases were used for the initial search of this study from database inception until 22 September 2023. The inclusion criteria required articles that examined the outcomes for surgery for ASD, stratified outcomes by surgeon experience and/or the learning curve as a proxy for surgeon experience, and utilized adult patients (>18 years of age). Seven articles met the criteria for final inclusion. Patients in the Experienced Surgeon group had statistically significantly lower levels of EBL with no significant difference in operative time after surgery for ASD compared to patients in the Inexperienced Surgeon group via a meta-analysis of three articles. Patients in the Experienced Surgeon group had a statistically significantly lower total complication rate compared to patients in the Inexperienced Surgeon group via a meta-analysis. Increased surgeon experience resulted in lower levels of EBL, without a significant difference in the operative time after surgery for ASD.
Background: Though ubiquitously used in orthopaedic trauma, lower extremity splints may have associated iatrogenic risk of morbidity. Although clinicians pad bony prominences to minimize skin pressure, the effect of joint position on skin pressure and, more specifically, changing joint position, is understudied. The purpose of this biomechanical study is to determine the effect of various short-leg splint application techniques on anterior ankle surface pressure in the development of iatrogenic skin pressure ulcers. Methods: Various constructs of lower extremity, short-leg splints were applied to 3 healthy subjects (6 limbs total) with an underlying pressure transducer (Tekscan I-Scan system) on the skin surface centered on the tibialis anterior tendon at the level of the ankle. All subjects underwent anterior ankle surface pressure assessment when padding was applied in maximum plantar flexion and neutral position for conventional short-leg splints application in clinically relevant patient scenarios. Percentage change from initial contact pressure centered on the tibialis anterior with cast padding were calculated. Results: The percentage change in anterior ankle contact pressure when padding was applied in maximum plantar flexion (PF) and then definitively placed in neutral was increased at least 2-fold without the addition of plaster in lower extremity short-leg splints. Removing anterior ankle padding following final splint application in neutral reduced contact forces at the anterior ankle 46% and 59% in splints applied in maximum PF and neutral ankle position, respectively. Conclusion: The present study is the first of its kind to underscore and quantify clinically relevant technical pearls that can be useful in reducing risk of iatrogenic risk of skin breakdown at the anterior ankle when placing short-leg splints, mainly, that it is imperative to apply padding in the intended final splint position and to remove anterior ankle padding following splint application when able. Level of Evidence: Level IV, biomechanical study with clear hypothesis.
Hip-spine syndrome, characterized by coexisting hip arthritis and degenerative lumbar spine disease, is prevalent in the aging population. While prior research has examined how lumbar spinal fusion (LSF) affects total hip arthroplasty (THA) outcomes, the impact of THA on lumbar-specific outcomes after LSF remains underexplored. This systematic review consolidates evidence on how THA timing and presence influence lumbar-specific outcomes and complications in patients undergoing LSF. To our knowledge, no prior systematic review has been performed on this topic. A comprehensive search of 4 databases through January 19, 2024, identified 6 articles for inclusion. Studies were evaluated using the Methodological Index for Non-Randomized Studies scale, with all articles deemed of moderate quality. Data from 271,008 patients revealed that individuals undergoing THA before LSF exhibited higher Oswestry Disability Index scores and lower Harris Hip Scores than those undergoing THA after LSF. THA performed after LSF was associated with increased risks of adjacent segment disease, pseudarthrosis, revision LSF, and mechanical failure. Additionally, LSF performed within 2 years after THA showed elevated risks of deep vein thrombosis, neurological complications, and prolonged opioid use. Lumbar-specific complications are increased following concomitant THA and LSF and may be affected by the order the surgeries are performed. Strategic planning of surgical interventions is essential to optimize outcomes for patients with concomitant hip and lumbar spine pathology.